New renders of what the iPhone 17 Pro and iPhone 17 Pro Max could look like have been shared by a serial leaker, complete ...

After earlier reports suggested that Apple could position the logo lower on the iPhone 17 Pro, new renders have emerged showing how this might happen ...

In the last 3 months, 6 analysts have offered 12-month price targets for Prometheus Biosciences. The company has an average price target of $176.33 with a high of $225.00 and a low of $139.00.

Prometheus (RXDX) is set to be acquired by Merck for $11 billion, adding Prometheus' lead product candidate, PRA023, to Merck's portfolio. Prometheus' stock is up 70%.

Quoting analysts, Prometheus has predicted that the inflammatory bowel disease market will be worth upward of $49 billion by 2030. That opportunity alone could establish PRA023 as a big ...

Shares of Prometheus Biosciences soared 70% in premarket trading on Monday after Merck & Co. announced that it would acquire the company in a $10.8 billion deal. The deal, announced Sunday, gives ...

April 16 (Reuters) - Merck & Co (MRK.N) said on Sunday it will buy Prometheus Biosciences Inc (RXDX.O) for about $10.8 billion, picking up a promising experimental treatment for ulcerative colitis ...

Prometheus writer Damon Lindelof in 2012 imagined Peter Weyland (Guy Pearce) in today’s world, giving a TED Talk. But what did it actually get right about the future?

Colorado-based Prometheus Materials has developed masonry blocks from a low-carbon cement-like material grown from micro-algae. The blocks, which meet the American Society for Testing and ...

The product, with 2,000-psi compressive strength, will be marketed as an affordable, strong and durable near-zero-carbon alternative to portland cement-based concrete masonry units, says Prometheus.